TNFRSF17 and Miyoshi myopathy: B‐cell maturation antigen (BCMA), a member of the tumor necrosis factor superfamily proteins, is specifically highly expressed on malignant and normal plasma cells and some mature B cells, making it a potential target for MM.16, 17, 18, 19